Clinical trial
Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B…
NCT00347009 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00347009 |
|---|---|
| Title | Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis |
| Official title | An Open Label Study of Adefovir Dipivoxil for the Treatment of Patients With Chronic Hepatitis B Related Advanced Fibrosis or Cirrhosis. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis B, Chronic, Cirrhosis, Fibrosis, Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | adefovir dipivoxil |
| Enrollment | 155 |
| Start date | May 1, 2005 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Jul 4, 2006 |
| Last update posted | Jun 4, 2012 |
| Countries | Hong Kong, Singapore, South Korea, Taiwan, Vietnam |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: